SC 13G: Emergent BioSolutions Inc.

AI Summary

SC 13G filing by Emergent BioSolutions Inc..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securitie

Filing Documents

• p24-3235sc13g.htm (SC 13G) — 50KB
• 0000902664-24-006468.txt ( ) — 51KB

(a)

Item 1(a). NAME OF ISSUER: Emergent BioSolutions Inc. (the “ Company ”)

(b)

Item 1(b). ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES: 300 Professional Drive, Gaithersburg, MD 20879.

(a)

Item 2(a). NAME OF PERSON FILING: This Schedule 13G is being filed on behalf of Oak Hill Advisors, L.P., a Delaware limited partnership (“ OHA ” or, the “ Reporting Person ”), as investment adviser to certain funds and client accounts (directly or through an affiliate) (together, the “ Oak Hill Funds ”), with respect to the shares of Common Stock and the shares of Common Stock issuable upon exercise of warrants directly held by the Oak Hill Funds. OHA is a subsidiary business of T. Rowe Price Associates, Inc. (“ TRP ”). OHA’s beneficial ownership does not include any shares that may be beneficially owned by TRP. Glenn R. August, a United States citizen, is the Founder and Chief Executive Officer of OHA. Any disclosures herein with respect to persons other than the Reporting Person are made on information and belief after making inquiry to the appropriate party. The filing of this statement should not be construed in and of itself as an admission by the Reporting Person as to beneficial ownership of the securities reported herein.

(b)

Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: The address of the business office of the Reporting Person is One Vanderbilt Avenue, 16th Floor, New York, New York 10017.

(c)

Item 2(c). CITIZENSHIP: OHA is a Delaware limited partnership.

(d)

Item 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, par value $0.001 per share (the “ Common Stock ”)

(e)

Item 2(e). CUSIP NUMBER: 29089Q105 CUSIP No. 29089Q105 13G Page 4 of 6 Pages Item 3. IF THIS STATEMENT IS FILED PURSUANT TO Rules 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) Broker or dealer registered under Section 15 of the Act; (b) Bank as defined in Section 3(a)(6) of the Act; (c) Insurance company as defined in Section 3(a)(19) of the Act; (d) Investment company registered under Section 8 of the Investment Company Act of 1940; (e) x An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k) Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution:______________________________ Item 4. The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page and is incorporated herein by reference. The percentage set forth in Row 11 of the cover page for the Reporting Person is calculated based upon 54,019,962 shares of Common Stock, which is the sum of (i) 52,906,624 shares of Common Stock outstanding as of July 30, 2024, as reported in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024, filed with the Securities and Exchange Commission on August 7, 2024 and (ii) 1,113,338 shares of Common Stock issued by the Company on September 17, 2024, as disclosed in the Company’s Current Report on Form 8-K filed with the

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. DATE: November 13, 2024 oak hill advisors, l.p. By: /s/ Gregory S. Rubin Name: Gregory S. Rubin Title: Authorized Signatory

View Full Filing

View this SC 13G filing on SEC EDGAR